COMMUNIQUÉS West-GlobeNewswire

ProLynx announces publication and initiation of patient recruitment for a trial of once-monthly treatment of diabetes in cats
05/09/2019
SAN FRANCISCO, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Today, ProLynx announced publication of data supporting therapy of Type 2 diabetes in cats with PLX039, a GLP-1 receptor agonist that can be administered once every [...]
La Jolla Pharmaceutical Company to Present at the 21st Annual H.C. Wainwright Global Investment Conference
05/09/2019
SAN DIEGO, Sept. 05, 2019 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve [...]
athenahealth Welcomes Paul Brient as Chief Product Officer
05/09/2019
Former PatientKeeper CEO and Industry Innovator to Drive Product Strategy for Healthcare IT Pioneer WATERTOWN, Mass., Sept. 05, 2019 (GLOBE NEWSWIRE) -- athenahealth, Inc., a leading provider of network-enabled services [...]
HearAtLast Holdings Acquires 100% of Fast Growing Canadian Start-up Crystal Clear Audio
05/09/2019
LAS VEGAS, NV, Sept. 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- HearAtLast Holdings, Inc. (OTC:HRAL) , a holding company currently involved in restructuring and expanding its business model, revenue and asset base [...]
AMAG Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference
05/09/2019
WALTHAM, Mass., Sept. 05, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) will participate in the Morgan Stanley Global Healthcare Conference on Tuesday, September 10, 2019. Bill Heiden, president and [...]
Forward Pharma to Participate in the Fall Investor Summit in New York
05/09/2019
COPENHAGEN, Denmark, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”) today announced that Chief Executive Officer, Dr. Claus Bo Svendsen, will participate in the Fall Investor Summit [...]
Tula Health Closes $2.6 Million Seed Round to Develop Personalized Digital Health Platform
05/09/2019
KAYSVILLE, Utah, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Tula Health, Inc, a transformative personalized digital health platform that continuously and noninvasively monitors blood glucose and key health metrics through its [...]
Aeglea BioTherapeutics to Present at 21st Annual H.C. Wainwright Global Investment Conference
05/09/2019
Live Webcast Scheduled for 5:30 p.m. ET on Monday, September 9 AUSTIN, Texas, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company that engineers next- [...]
Aclaris Therapeutics Announces New Strategic Direction
05/09/2019
Completion of Strategic Review and Refocusing of Resources on Immuno-Inflammatory Development Pipeline Actively Seeking a Commercialization Partner for RHOFADE® (oxymetazoline hydrochloride) cream, 1% Actively Exploring [...]
INmune Bio to Present at the H.C. Wainwright 21st Annual Healthcare Conference on Tuesday, September 10th at 2:10 p.m. ET
05/09/2019
LA JOLLA, Calif., Sept. 05, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB ), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, is pleased [...]
Fortress Biotech to Present at September 2019 Investor Conferences
05/09/2019
NEW YORK, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on identifying, in-licensing and developing high-potential marketed and [...]
Genprex (GNPX) Featured in NetworkNewsWire Publication Summarizing Gene Therapy Treatment for Lung Cancer
05/09/2019
NEW YORK, Sept. 05, 2019 (GLOBE NEWSWIRE) -- via NetworkWire — Genprex Inc. (NASDAQ: GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing [...]
Cronos Group Inc. Closes Redwood Holding Group Acquisition
05/09/2019
TORONTO, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”) today announced that it has closed its previously announced acquisition of four Redwood [...]
Better Choice Company Announces Marketing Partnership with iHeartMedia
05/09/2019
NEW YORK, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (OTCQB: BTTR) (the “Company” or “Better Choice”), an animal health and wellness CBD company, today announced a new media partnership with [...]
American BriVision Announces Strategic Collaboration with BioLite Japan
05/09/2019
Collaboration combines BioLite Japan’s early-stage discovery capabilities with the Company’s clinical trial expertise BioLite Japan’s expertise in academic and medical community in Japan and APAC region brings new [...]
Catalyst Biosciences to Present at the 2019 ASBMB Symposium on Serine Proteases in Pericellular Proteolysis and Signaling Conference
05/09/2019
SOUTH SAN FRANCISCO, Calif., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO), today announced an oral presentation at the 2019 American Society for Biochemistry and Molecular Biology (ASBMB [...]
VBI Vaccines to Present at the H.C. Wainwright 21st Annual Global Investment Conference
05/09/2019
CAMBRIDGE, Mass., Sept. 05, 2019 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) ("VBI"), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, [...]
Alimera Sciences Board of Directors Approves Reverse Stock Split and 10b5-1 Stock Purchase Plan for U.S. Executive Management
05/09/2019
ATLANTA, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a leader in the commercialization and development of prescription ophthalmology treatments for the management of retinal [...]
GBT Announces U.S. Food and Drug Administration Acceptance of New Drug Application and Priority Review for Voxelotor for the Treatment of Sickle Cell Disease
05/09/2019
Priority Review Shortens FDA Review Time to Six Months from Standard 10 Months NDA Supported by Data from Phase 3 HOPE Study, which Demonstrated Statistically Significant and Sustained Improvements in Hemoglobin with [...]

Pages